ArticleMaterials today. Bio2026
Mussel-inspired adhesive hydrogel reprograms osteoimmune niche for robust bone regeneration in complex defects.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Enhanced hemostasis and bone regeneration achieved by thrombin-simvastatin-polydopamine loaded spray-dried β-TCP/ gelatin/ soy protein isolate biocomposites in critical rat calvarial defects.Materials today. Bio · 2026Article
- How Emerging Nanomaterials are Effective in Bone Regeneration?International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex bone defects with irregular geometry, interfacial micro-motion and compromised immune microenvironment pose a formidable clinical challenge. Ideal bone repair materials should simultaneously achieve robust interfacial integration and actively regulate the osteoimmunological milieu. Herein, we developed an injectable and photo-curable double-network hydrogel, termed DPG@MA, based on mussel-inspired chemistry and a nanocomposite strategy. The hydrogel features a dynamically cross-linked network formed by a 3,4-dihydroxyphenylalanine (DOPA)-pectin conjugate (DP) and gelatin methacryloyl (GelMA), enabling stable and conformal adhesion to irregular bone defects. Furthermore, the incorporation of alendronate-loaded mesoporous silica nanoparticles (MA) confers the hydrogel with the capacity for sustained co-release of silicon ions and alendronate, effectively steering macrophage polarization from the pro-inflammatory M1 phenotype toward the pro-healing M2 phenotype. This actively reshapes the immune microenvironment into one conducive to bone regeneration. In rat calvarial and tibial defect models, DPG@MA significantly enhanced bone regeneration and osseointegration while mitigating complications, outperforming the clinical standard Novabone®. This study proposes a novel strategy for designing bone repair materials with integrated "interfacial adhesion-immunomodulation-osteogenesis" functionality, offering a promising therapeutic avenue for complex bone defects with challenging healing barriers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.